Stay updated on iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH transition notice appears above the ClinicalTrials.gov page, and the site revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T19:16:17.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-06T21:36:20.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the previous content. This indicates that access to the page is blocked and the normal study details are not visible.
    Difference
    19%
    Check dated 2026-09-22T23:54:02.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0. This indicates a backend update to the page without changes to the displayed study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:01:25.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor maintenance update to the study page with no evident changes to study content.
    Difference
    0.1%
    Check dated 2026-09-01T20:33:04.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, signaling a new build or update to the page content. This is a routine maintenance version change rather than a content change affecting study details.
    Difference
    0.1%
    Check dated 2026-08-11T18:30:06.000Z thumbnail image

Stay in the know with updates to iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the iRECIST DCR Evaluation in MMR/MSI CRC on Nivolumab+Ipilimumab Clinical Trial page.